title: Peripheral blood leukocytes as a surrogate marker for cisplatin drug resistance: studies of adduct levels and the repair gene ERCC1.
authors.affiliation: Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland 20892.
authors.forename: R J
authors.initials: RJ
authors.lastname: Parker
authors.forename: M C
authors.initials: MC
authors.lastname: Poirier
authors.forename: F
authors.initials: F
authors.lastname: Bostick-Bruton
authors.forename: J
authors.initials: J
authors.lastname: Vionnet
authors.forename: V A
authors.initials: VA
authors.lastname: Bohr
authors.forename: E
authors.initials: E
authors.lastname: Reed
mesh_terms: D000818:Animals; D016190:Carboplatin / Q000627:therapeutic use*; D002460:Cell Line; D002945:Cisplatin / Q000494:pharmacology / Q000627:therapeutic use*; D004247:DNA / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification; D004249:DNA Damage; D004260:DNA Repair; D004351:Drug Resistance / Q000235:genetics; D005260:Female; D006801:Humans; D007962:Leukocytes / Q000187:drug effects / Q000378:metabolism*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D011379:Prognosis; D012313:RNA / Q000235:genetics / Q000302:isolation & purification
chemical_list: D012313:RNA; D004247:DNA; D016190:Carboplatin; D002945:Cisplatin